HCM stock Statistics — HUTCHMED (China) Ltd filings, insiders & smart money

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Beta: Sign in
Shares outstanding: —
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interest: —
Short ratioDays to cover, as published by FINRA: 2.31
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 30.50%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 37.30%
Avg volume (10D): Sign in
Avg volume (3 months)

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Gross marginFY Dec 25: 38.68%
Operating marginFY Dec 25: -7.14%
Net margin: —
EBITDA marginFY Dec 25: -4.71%
Return on equityNet income (FY Dec 25) ÷ average shareholders equity: 45.74%
Return on assetsNet income (FY Dec 25) ÷ average total assets: 30.19%

Cash & equivalentsas of Dec 25: $71.33M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Dec 25: $122.86M
Debt / equityas of Dec 25: 9.92%
Current ratioas of Dec 25: 4.96
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Dec 25: 4.73
Operating cash flowFY Dec 25: -$64.65M
Free cash flowUnadjusted FCF = CFO − capex · FY Dec 25: -$78.80M
TTM revenue / diluted share: —